Cerevel Therapeutics Holdings, Inc. (CERE) has 67 open-market insider trades by 25 insiders since 2012. The most active filer is John Renger, CSO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Christopher R. Gordon | Dir10% Owner | — | 3 | $356.8M | 2024-08-01 |
| Adam Koppel | Dir10% Owner | — | 3 | $356.8M | 2024-08-01 |
| BAIN Capital Investors LLC | 10% Owner | — | 1 | $125.0M | 2023-10-16 |
| Perceptive LIFE Sciences Master FUND Ltd. via Joseph Edelman | Dir | — | 3 | $84.9M | 2022-08-16 |
| Joseph Edelman | Dir | — | 2 | $44.1M | 2023-10-16 |
| John Renger | CSO | — | 17 | $16.2M | 2024-08-01 |
| N. Anthony Coles | Dir | — | 9 | $11.0M | 2024-08-01 |
| Administratiekantoor Westend Stichting | 10% | — | 1 | $11.0M | 2012-02-27 |
| Perceptive Advisors LLC | Dir | — | 1 | $9.7M | 2024-02-20 |
| Marijn E. Dekkers | Dir | — | 1 | $6.9M | 2024-08-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| N. Anthony Coles | Director | Sell | $1.0M | 2024-07-01 |
| N. Anthony Coles | Director | Sell | $2.0M | 2024-06-03 |
| N. Anthony Coles | Director | Sell | $2.1M | 2024-05-10 |
| N. Anthony Coles | Director | Sell | $2.1M | 2024-04-01 |
| N. Anthony Coles | Director | Sell | $2.1M | 2024-03-04 |
| N. Anthony Coles | Director | Sell | $4.1M | 2024-02-29 |
Companies that share insiders with CERE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John Renger | CSO | Sell | $180K | 2024-02-07 |
| N. Anthony Coles | Director | Sell | $208K | 2024-02-07 |
| N. Anthony Coles | Director | Sell | $2.1M | 2024-01-02 |
| Ramiro Sanchez | — | Sell | $425K | 2023-12-26 |
| Kenneth DiPietro | CHRO | Sell | $332K | 2023-12-22 |
| Susan Altschuller | CFO | Sell | $1.1M | 2023-12-20 |
| Kathleen Tregoning | — | Sell | $521K | 2023-12-20 |
| Ramiro Sanchez | — | Sell | $841K | 2023-12-20 |
| Kenneth DiPietro | CHRO | Sell | $518K | 2023-12-20 |